NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28404595)

Published in J Exp Med on April 12, 2017

Authors

Leslie Freeman1,2, Haitao Guo1, Clément N David1, W June Brickey1, Sushmita Jha3,4, Jenny P-Y Ting5,6

Author Affiliations

1: Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
2: Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
3: Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 jenny_ting@med.unc.edu sushmitajha@gmail.com.
4: Indian Institute of Technology Jodhpur, Rajasthan 342011, India.
5: Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America.
6: Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, United States of America.

Articles cited by this

NIH Image to ImageJ: 25 years of image analysis. Nat Methods (2012) 84.41

Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature (2006) 24.43

The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell (2002) 20.11

Cryopyrin activates the inflammasome in response to toxins and ATP. Nature (2006) 18.74

Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature (2004) 14.80

AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature (2009) 13.23

Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol (1980) 11.52

Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci (2007) 11.11

AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature (2009) 10.83

Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity (2006) 10.58

Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol (2006) 10.55

The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol (2008) 10.39

Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature (2006) 9.77

NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell (2011) 9.75

Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol (2006) 9.64

An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol (2009) 7.93

The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol (2010) 7.47

Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet (2006) 6.89

Inflammasomes in health and disease. Nature (2012) 6.75

Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature (2011) 6.38

The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature (2011) 6.21

Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med (2006) 6.15

Active caspase-1 is a regulator of unconventional protein secretion. Cell (2008) 5.89

Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci U S A (2010) 5.59

Regulation of Legionella phagosome maturation and infection through flagellin and host Ipaf. J Biol Chem (2006) 5.11

Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J Exp Med (2007) 4.95

Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog (2007) 4.73

The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med (2010) 4.37

Differential requirement for Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing. Cell Host Microbe (2010) 4.10

Immune function of astrocytes. Glia (2001) 4.05

NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature (2012) 3.67

TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci (2001) 3.50

The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol (2001) 3.47

The sterile inflammatory response. Annu Rev Immunol (2010) 3.45

Regulation of innate immune responses in the brain. Nat Rev Immunol (2009) 3.41

Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J Biol Chem (2001) 3.37

CATERPILLER: a novel gene family important in immunity, cell death, and diseases. Annu Rev Immunol (2005) 3.04

Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med (2015) 2.59

Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling. Proc Natl Acad Sci U S A (2007) 2.48

An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet (2014) 2.40

Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc Natl Acad Sci U S A (2010) 2.33

The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J Biol Chem (2007) 2.31

Astrocytes and disease: a neurodevelopmental perspective. Genes Dev (2012) 2.28

An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages. Immunity (2012) 2.01

Human NAIP and mouse NAIP1 recognize bacterial type III secretion needle protein for inflammasome activation. Proc Natl Acad Sci U S A (2013) 1.97

A molecular platform in neurons regulates inflammation after spinal cord injury. J Neurosci (2008) 1.93

Microglial clearance function in health and disease. Neuroscience (2008) 1.84

Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis. Glia (2002) 1.74

Neuroinflammatory processes in Alzheimer's disease. J Neural Transm (Vienna) (2010) 1.73

The NLRP12 inflammasome recognizes Yersinia pestis. Immunity (2012) 1.70

Inflammasomes as microbial sensors. Eur J Immunol (2010) 1.70

Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury. J Cereb Blood Flow Metab (2009) 1.69

Cutting edge: NLRC5-dependent activation of the inflammasome. J Immunol (2010) 1.66

CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis. Nat Neurosci (2010) 1.65

NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens. Nature (2012) 1.63

Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. J Neuroimmunol (1998) 1.63

Inflammasome activation causes dual recruitment of NLRC4 and NLRP3 to the same macromolecular complex. Proc Natl Acad Sci U S A (2014) 1.50

Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol Rev (2006) 1.50

Cryo-EM structure of the activated NAIP2-NLRC4 inflammasome reveals nucleated polymerization. Science (2015) 1.48

Polymorphisms in NACHT-LRR (NLR) genes in atopic dermatitis. Exp Dermatol (2007) 1.46

Structural and biochemical basis for induced self-propagation of NLRC4. Science (2015) 1.42

Formation and structure of a NAIP5-NLRC4 inflammasome induced by direct interactions with conserved N- and C-terminal regions of flagellin. J Biol Chem (2012) 1.41

Cutting edge: Mouse NAIP1 detects the type III secretion system needle protein. J Immunol (2013) 1.38

The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18. J Neurosci (2010) 1.37

Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol (2016) 1.27

The pleiotropic functions of interleukin 15: not so interleukin 2-like after all. J Exp Med (2000) 1.22

Human CARD12 is a novel CED4/Apaf-1 family member that induces apoptosis. Biochem Biophys Res Commun (2001) 1.21

The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease. J Immunol (2002) 1.14

Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies. PLoS One (2013) 1.11

Cytosolic flagellin receptor NLRC4 protects mice against mucosal and systemic challenges. Mucosal Immunol (2012) 1.08

The inflammasomes and autoinflammatory syndromes. Annu Rev Pathol (2014) 1.08

Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease. Clin Exp Immunol (2009) 1.03

Pattern recognition receptors and central nervous system repair. Exp Neurol (2014) 1.02

Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factors. Dig Dis (2012) 1.01

Lysophosphatidylcholine as a ligand for immunoregulation. Biochem Pharmacol (2002) 1.01

Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelination. Toxicol Lett (2007) 1.01

Pyroptotic neuronal cell death mediated by the AIM2 inflammasome. J Cereb Blood Flow Metab (2014) 1.00

The lysophospholipid receptor G2A activates a specific combination of G proteins and promotes apoptosis. J Biol Chem (2003) 0.99

Lysophosphatidylcholine stimulates IL-1beta release from microglia via a P2X7 receptor-independent mechanism. J Immunol (2006) 0.98

Rhinovirus-induced calcium flux triggers NLRP3 and NLRC5 activation in bronchial cells. Am J Respir Cell Mol Biol (2013) 0.95

Interaction of NG2(+) glial progenitors and microglia/macrophages from the injured spinal cord. Glia (2010) 0.94

The pathogenic role of the inflammasome in neurodegenerative diseases. J Neurochem (2015) 0.94

The protective role of nitric oxide in a neurotoxicant-induced demyelinating model. J Immunol (2002) 0.91

Lymphotoxin beta receptor (Lt betaR): dual roles in demyelination and remyelination and successful therapeutic intervention using Lt betaR-Ig protein. J Neurosci (2007) 0.90

Expression of G2A, a receptor for lysophosphatidylcholine, by macrophages in murine, rabbit, and human atherosclerotic plaques. Arterioscler Thromb Vasc Biol (2002) 0.89

Cryoelectron Tomography of the NAIP5/NLRC4 Inflammasome: Implications for NLR Activation. Structure (2015) 0.88

Lysophosphatidyl choline-induced focal demyelination in the rabbit corpus callosum. Light-microscopic observations. J Neurol Sci (1979) 0.87

AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3. Proc Natl Acad Sci U S A (2015) 0.86

NLRP3 recruitment by NLRC4 during Salmonella infection. J Exp Med (2016) 0.85

Physiological mechanisms of lysophosphatidylcholine-induced de-ramification of murine microglia. J Physiol (2004) 0.84

IPAF inflammasome is involved in interleukin-1β production from astrocytes, induced by palmitate; implications for Alzheimer's Disease. Neurobiol Aging (2013) 0.82

Regulation of MHC class II expression in the central nervous system. Microbes Infect (1999) 0.80

An in vitro model for de- and remyelination using lysophosphatidyl choline in rodent whole brain spheroid cultures. Glia (2009) 0.79

Obesity-associated NLRC4 inflammasome activation drives breast cancer progression. Nat Commun (2016) 0.79

Lysophosphatidylcholine modulates fibril formation of amyloid beta peptide. FEBS J (2011) 0.77

Focal experimental demyelination in monkey optic nerve by lysophosphatidylcholine. Jpn J Ophthalmol (1985) 0.76